Literature DB >> 12789176

UV photoprotection by combination topical antioxidants vitamin C and vitamin E.

Jing-Yi Lin1, M Angelica Selim, Christopher R Shea, James M Grichnik, Mostafa M Omar, Nancy A Monteiro-Riviere, Sheldon R Pinnell.   

Abstract

BACKGROUND: Virtually all plants and animals protect themselves from the sun using vitamins C and E.
OBJECTIVE: The purpose of this study was to see if a combination of topical vitamins C and E is better for UV protection to skin than an equivalent concentration of topical vitamin C or E alone.
METHODS: We developed a stable aqueous solution of 15% L-ascorbic acid (vitamin C) and 1% alpha-tocopherol (vitamin E). We applied antioxidant or vehicle solutions to pig skin daily for 4 days. We irradiated (1-5x minimal erythema dose) control- and antioxidant-treated skin using a solar simulator with a 295-nm band-pass filter. On day 5, we measured antioxidant protection factor, erythema, sunburn cells, and thymine dimers.
RESULTS: The combination of 15% L-ascorbic acid and 1% alpha-tocopherol provided significant protection against erythema and sunburn cell formation; either L-ascorbic acid or 1% alpha-tocopherol alone also was protective but the combination was superior. Application during 4 days provided progressive protection that yielded an antioxidant protection factor of 4-fold. In addition, the combination of vitamins C and E provided protection against thymine dimer formation.
CONCLUSION: Appreciable photoprotection can be obtained from the combination of topical vitamins C and E. We suggest that these natural products may protect against skin cancer and photoaging.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12789176     DOI: 10.1067/mjd.2003.425

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  47 in total

Review 1.  [Sunscreens. Protection against skin cancers and photoaging].

Authors:  P Wolf
Journal:  Hautarzt       Date:  2003-09       Impact factor: 0.751

Review 2.  [Active ingredients in dermatocosmetics].

Authors:  T Reuther; M Kerscher
Journal:  Hautarzt       Date:  2004-07       Impact factor: 0.751

3.  Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.

Authors:  Erica C Davis; Valerie D Callender
Journal:  J Clin Aesthet Dermatol       Date:  2010-07

Review 4.  The Tricky Tear Trough: A Review of Topical Cosmeceuticals for Periorbital Skin Rejuvenation.

Authors:  Stacey J Pilkington; Sarah Belden; Richard A Miller
Journal:  J Clin Aesthet Dermatol       Date:  2015-09

5.  [Skin aging and evidence-based topical strategies].

Authors:  C Bayerl
Journal:  Hautarzt       Date:  2016-02       Impact factor: 0.751

Review 6.  [Topical treatment of skin aging].

Authors:  C Bayerl
Journal:  Hautarzt       Date:  2005-04       Impact factor: 0.751

7.  Temperature-sensitive microemulsion gel: an effective topical delivery system for simultaneous delivery of vitamins C and E.

Authors:  Branka Rozman; Alenka Zvonar; Francoise Falson; Mirjana Gasperlin
Journal:  AAPS PharmSciTech       Date:  2009-01-16       Impact factor: 3.246

8.  [Skin aging].

Authors:  E Kohl; M Landthaler; R-M Szeimies
Journal:  Hautarzt       Date:  2009-11       Impact factor: 0.751

9.  Brazilian consensus on photoprotection.

Authors:  Sérgio Schalka; Denise Steiner; Flávia Naranjo Ravelli; Tatiana Steiner; Aripuanã Cobério Terena; Carolina Reato Marçon; Eloisa Leis Ayres; Flávia Alvim Sant'anna Addor; Helio Amante Miot; Humberto Ponzio; Ida Duarte; Jane Neffá; José Antônio Jabur da Cunha; Juliana Catucci Boza; Luciana de Paula Samorano; Marcelo de Paula Corrêa; Marcus Maia; Nilton Nasser; Olga Maria Rodrigues Ribeiro Leite; Otávio Sergio Lopes; Pedro Dantas Oliveira; Renata Leal Bregunci Meyer; Tânia Cestari; Vitor Manoel Silva dos Reis; Vitória Regina Pedreira de Almeida Rego
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

Review 10.  Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.

Authors:  Joanne M Jeter; Tawnya L Bowles; Clara Curiel-Lewandrowski; Susan M Swetter; Fabian V Filipp; Zalfa A Abdel-Malek; Larisa J Geskin; Jerry D Brewer; Jack L Arbiser; Jeffrey E Gershenwald; Emily Y Chu; John M Kirkwood; Neil F Box; Pauline Funchain; David E Fisher; Kari L Kendra; Ashfaq A Marghoob; Suephy C Chen; Michael E Ming; Mark R Albertini; John T Vetto; Kim A Margolin; Sherry L Pagoto; Jennifer L Hay; Douglas Grossman; Darrel L Ellis; Mohammed Kashani-Sabet; Aaron R Mangold; Svetomir N Markovic; Frank L Meyskens; Kelly C Nelson; Jennifer G Powers; June K Robinson; Debjani Sahni; Aleksandar Sekulic; Vernon K Sondak; Maria L Wei; Jonathan S Zager; Robert P Dellavalle; John A Thompson; Martin A Weinstock; Sancy A Leachman; Pamela B Cassidy
Journal:  Cancer       Date:  2018-10-03       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.